Changes in cell behavior induced by extracellular signaling molecules such as growth factors and cytokines require execution of a complex program of transcriptional events. While the route followed by the intracellular signal from the cell membrane to its transcription factor targets can be traced in an increasing number of cases, how the specificity of the transcriptional response of the cell to different stimuli is determined is much less clear. However, it is possible to understand at least in principle how different stimuli can activate the same signal pathway yet activate different genes and how small differences in signal strength can generate qualitative differences in gene expression.
Changes in cell behavior induced by extracellular signaling molecules such as growth factors and cytokines require execution of a complex program of transcriptional events. While the route followed by the intracellular signal from the cell membrane to its transcription factor targets can be traced in an increasing number of cases, how the specificity of the transcriptional response of the cell to different stimuli is determined is much less clear. However, it is possible to understand at least in principle how different stimuli can activate the same signal pathway yet activate different genes and how small differences in signal strength can generate qualitative differences in gene expression.
In this review we shall concentrate on transcriptional responses to cell surface receptor-activated signaling pathways; however, much of our discussion is also applicable to signals induced by environmental stresses or to extracellular signals that act directly on transcription factors, such as steroid hormones. Rather than describe in detail each of the many separate pathways from receptor to transcription factor, we have attempted to compare and contrast regulation of a representative set of transcription factors. These factors are introduced in Figure 1 , and their properties are summarized in Table 1 . To set the stage, we briefly discuss the different properties of transcription factors that can be modified to regulate their behavior in response to signals. We then use relatively well-characterized signaling pathways to illustrate different strategies by which an extracellular stimu lus is converted to an active transcription factor in the nucleus. Finally, we use these examples to illustrate two aspects of specificity in the transcriptional response to signals: first, the means by which a given stimulus specifically targets particular transcription factors and DNA targets; and second, the means by which differential responses to qualitatively and quantitatively different signals can be generated.
Mechanisms of Regulation
To activate or repress transcription, transcription factors must be located in the nucleus, bind DNA, and interact with the basal transcription apparatus. Accordingly, extracellular signals that regulate transcription factor activity may affect one or more of these processes. Most commonly, regulation is achieved by reversible phosphorylation (for review see Hunter and Karin, 1992) . Phosphorylation of a transcription factor by several different kinases (or by a kinase linked to more than one pathway) is a simple mechanism that allows different signals to converge at the same factor.
Review Nuclear Translocation
In principle, regulated nuclear localization of transcription factors can involve regulated activity of either nuclear localization signals (NLSs) or cytoplasmic retention signals, although no well-characterized case of the latter has yet been reported. N LS activity, which is generally dependent on short regions of basic amino acids, can be regulated either by masking mechanisms or by phosphorylations within the NLS itself (Hunter and Karin, 1992) . For example, association with an inhibitory subunit masks the NLS of NF-KB and its relatives (Figure 1 ; for review see , while an intramolecular mechanism may mask NLS activity in the heat shock regulatory factor HSF2 (Sheldon and Kingston, 1993) . When transcription factor localization is dependent on regulated NLS activity, linkage to a constitutively acting NLS may be sufficient to render nuclear localization independent of signaling (Beg et al., 1992) .
DNA Binding
Many DNA-binding proteins bind DNA as oligomers, and signals can therefore regulate DNA binding by affecting factor oligomerization as well as protein-DNA interaction itself. For example, signals may induce dissociation of transcription factors from inhibitory molecules that may either directly block DNA-binding domain-DNA interactions, as in the case of certain NF-~<B-h<B complexes (see , or prevent dimerization of the factor subunits, as in certain nuclear receptors (see Gronemeyer, 1993) . Alternatively, subunit association itself can be regulated: for example, signal-induced tyrosine phosphorylation induces STAT (signal transducer and activator of transcription) factor dimerization, probably via mutual phosphotyrosine-SH2 domain interactions (Figure 1 ; Shuai et al., 1994) , while heat shock activates HSF (heat shock factor) trimerization via an unknown but apparently phosphorylation-independent mechanism (Lis and Wu, 1993; Westwood and Wu, 1993) .
Since many DNA-binding domains are basic in character, phosphorylation at sites within or near DNA-binding domains may prevent DNA binding, perhaps by direct electrostatic effects. For example, signal-induced dephosphorylation of three sites adjacent to the Jun DNA-binding domain potentiates DNA binding (Figure 1 ; Binetruy et al., 1991 ; Boyle et al., 1991) . DNA-binding properties can also be regulated by phosphorylation at remote sites, as in the growth factor-regulated changes in the DNA-binding properties of serum response factor (SRF) (Rivera et al., 1993) and its accessory factor, the ternary complex factor (TCF) Elk-1 (Figure 1 ; Gille et al., 1992) ; however, the mechanisms underlying such effects remain obscure.
Transcriptional Activation
A number of transcription factors contain signal-regulated transcriptional activation domains: in these cases, it is presumed that regulated phosphorylation facilitates their interaction with the basal transcriptional machinery or coactivator proteins, although the mechanisms by which this Where the transcription factor is a member of a family, a single example has been illustrated. Hatching, DNA-binding domains; vertical lines, regulated phosphorylation sites. In Elk-l, the three stippled boxes indicate regions of homology between TCF family members. In CREB, the glutamine-rich domains that are absent in CREM isoforms are indicated (Q1 and Q2). The kinase-inducible domain (KID) contains the phosphorylated Ser-133 and multiple other phosphorylation sites. In Jun, the 8 domain that is absent in v-Jun is indicated. In STAT1 the DNA-binding domain has not been mapped. The regions of Src homology (SH2 and SH3) are indicated. In NF-KB the Rel homology domain is shown, which is conserved in all other members of the family. The inhibitor of NF-~<B, IKB, is also shown. In NF-ATp the region of weak Rel similarity that contains the DNA-binding domain is indicated.
potentiates transcriptional initiation remain only poorly understood. For example, transcriptional activation by the extensively studied transcription factor CREB (cAMP response element-binding protein) is dependent on regulated phosphorylation at Ser-133; this can be brought about independently by protein kinase A-, calmodulin-, or nerve growth factor-induced kinases and is thus a convergence point for different signaling pathways (Gonzalez and Montminy, 1989; Sheng et al., 1991; Ginty et al., 1994) . Ser-133 phosphorylation allows CREB to associate with a coactivator protein, CBP (Chrivia et al., 1993; Arias et al., 1994; Kwok et al., 1994) ; however, this does not appear to be sufficient for transcriptional activation, which also involves neighboring glutamine-rich domains ( Figure  1 ; for review see Lalli and Sassone-Corsi, 1994 ; see also Gonzalez and Montminy, 1989; Brindle et al., 1993; AIberts et al., 1994a; Ferreri et al., 1994) . In the case of CREB, interaction with either specific cofactors like CBP or the basal transcription machinery may be brought about by a phosphorylation-induced conformational change in the protein (Gon zalez et al., 1991) ; phosphorylation-induced conformation changes may also be important in regulated activation by the TCF Elk-1 (see below; for references see Treisman, 1994) .
Transcription Factor Activation Can Occur in the Nucleus, at the Cell Membrane, or in the Cytoplasm Activation of transcription factors by extracellular signals always involves a nuclear translocation step. Some pathways involve migration of signaling molecules themselves into the nucleus, while in others activated transcription factors migrate to the nucleus following their activation in the cytoplasm. Moreover, although in many cases activation of a single intracellular signaling pathway is sufficient for transcription factor activation, some transcription factors are complexes in which the activity of each component is regulated by different cellular signaling pathways. In this section we shall briefly review the representative examples of these strategies, which are summarized in Table 2 .
Activation in the Nucleus: MAP Kinase Pathways MAP kinases (MAPKs) are a family of protein.kinases whose prototype members are the mammalian extracellular signal-regulated kinases ERK1 and ERK2 and the Saccharomyces cerevisiae pheromone-regulated kinases KSS1 and FUS3. MAPK phosphorylation sites contain the core sequence motif S/T-P. A number of nuclear transcription factors have been identified as targets for MAPKs in metazoans, and MAPK signaling pathways provide relatively well-characterized examples of signaling cascades with nuclear targets.
The Ras/ERK MAPK Pathway
Activation of receptor tyrosine kinases activates a signaling cascade involving transient formation of ras-GTP and activation of raf kinase at the membrane, followed by sequential activation of MAPK kinase (MAPKK) and ERK1/ ERK2; only the latter enter the nucleus (for reviews see Marshall, 1994; Leevers et al., 1994; Stokoe et al., 1994) . In both mammalian cells and invertebrates, several transcription factor targets of this pathway, which we shall refer to as the ras/ERK pathway, have been defined. In S. cerevisiae, a related pathway, coupled to a serpentine receptor, activates the KSS1 and FUS3 MAPKs, causing activation of the STE12 transcription factor and transcription of pheromone-responsive genes (Herskowitz, 1995 [this issue of Cell]; see Table 3 ).
In mammalian cells, the ras/ERK pathway provides a common route by which signals from different growth factor receptors converge at a major regulatory element of the promoters of the c-foe and other coregulated genes, the serum response element (SRE). The major targets for the pathway in the c-foe promoter are the TCF proteins Elk-1 or SAP-l, whose activity is regulated by phosphorylation of a cluster of S/T-P motifs at their C-termini (see Table 1 ; Figure 1 ; for review see Treisman, 1994) . SRE mutations that prevent TCF binding substantially reduce a A specific example of a signaling pathway and transcription factor target is given in each case.
c-fos promoter activation by growth factors and mitogens or by intracellular activators of the pathway such as v-raf (Graham and Gilman, 1991; Kortenjann et al., 1994) , but regulation can be restored to such mutants by expression of appropriately altered DNA binding specificity derivatives of Elk-1 (Hill et al., 1994; Kortenjann et al., 1994) . Biochemical studies indicate that Elk-1 is a good substrate for ERKI/ERK2 in vitro, and the kinetics of its modification correlate well with MAPK activation in vivo (for review see Treisman, 1994) . Experiments with activated and interfering forms of MAPKK and ERK2 indicate that ERK activation is necessary for activation of Elk-1 and SAP-1 in vivo (Janknecht et al., 1993; Kortenjann et al., 1994) . However, a recent report indicates that SAP-1 may be activated by ras/ERK-independent pathways in certain cells (Hipskind et al., 1994) . Although phosphorylation can increase Elk-1 DNA binding in vitro under certain conditions (Gille et al., 1992) , the significance of this for SRE regulation remains unclear, since genomic footprinting indicates that an SRF-TCF complex binds the c-fos SRE constitutively in vivo (Herrera et al., 1989) . In Drosophila, the ras/ERK pathway apparently mediates cell fate determination in many different cell types. In the case of the Sevenless signaling pathway that controls photoreceptor R7 cell fate, nuclear transcription factor targets of the pathway have been identified; these include the Ets domain proteins pointed P2 and yan and the Drosophila Jun homolog dJun (for references see Bohmann et al., 1994; Brunner et al., 1994; O'Neill et al., 1994) . In vitro, pointed P2 and yan are substrates for the ERK2 homolog ERKA/rolled (Brunner et al., 1994) , while in transfection experiments, activation of the MAPK pathway stimulates activation by pointed P2 and inhibits a repressive function of yan, suggesting that yan and pointed P2 may have opposing effects on the same target promoters (Brunner et al., 1994; O'Neill et al., 1994) . The genetic data suggest that either loss of yan function or constitutive dJun function is sufficient for R7 cell determination. One possible explanation for this is that both yan/pointed p2 and dJun activate the same target promoters, perhaps through composite API/Ets motifs of the type first identified as ras-responsive elements in some mammalian promoters (Wasylyk et al., 1989; Gutman and Wasylyk, 1990) . Resolution of this question awaits the identification of target promoters for the pointed P2, yan, and dJun proteins.
The JNK/SAPK and Other MAPK Pathways
Studies of the mammalian Jun transcription factor led to the identification of the JNK/SAPKs (for Jun N-terminal/ stress-activated protein kinases) as a family of MAPKs distinct from the ERKs that are also regulated by extracellular signals (see Table 3 ; Hibi et al., 1993; D~rijard et al., 1994; Kyriakis et al., 1994; Davis, 1994) . Transcriptional activation by Jun, as with SAP-1 and Elk-l, requires phosphorylation at S/T-P motifs and can be potentiated by the Ras and Src oncoproteins ( Figure 1 ; Binetruy et al., 1991 ; Pulverer et al., 1991) . However, the two S/T-P motifs that a Not an exhaustive list. In a particular cell, the different kinase subfamilies may be independently regulated. FRK is characterized only as a proline-directed kinase. ° It remains unclear whether STE12 is a direct target for KSS1 or FUS3.
are phosphorylated in Jun are poor substrates for the ERKs but are efficiently phosphorylated by the JNKs/ SAPKs (see below). The activity of the JNKs/SAPKs can be regulated independently of that of the ERKs: agents that strongly stimulate Jun phosphorylation, such as ultraviolet light, strongly activate the J NKs/SAP Ks, but activate the ERKs only weakly (Devary et al., 1992; Hibi et al., 1993; Radler et al., 1993; Kyriakis et al., 1994) ; moreover, dominant interfering ERK mutants do not inhibit Jun activation (Westwick et al., 1994) . The regulation of JNKs/ SAPKs varies among different cell types, since in T cells JNK activation requires costimulation of both calcium-and protein kinase C (PKC)-dependent pathways . As mentioned above, Jun DNA-binding activity is regulated by dephosphorylation of sites adjacent to its DNA-binding domain (Binetruy et al., 1991; Boyle et al., 1991) , but it remains unclear whether this event is controlled by the JNK/SAPK pathway.
In mammalian cells, at least two other proline-directed kinases appear to be regulated independently of the ERKs and JNK/SAPKs: FRK, which phosphorylates the Fos transcriptional activation domain at Thr-232 , and RK/MPK2/p38 (Freshney et al., 1994; Han et al., 1994; Rouse et al., 1994 ), which appears to be the vertebrate homolog of the yeast MAPK HOG1 (Table 3; see Ammerer, 1994; Davis, 1994) . Phosphorylation of CREB in response to nerve growth factor may also involve a novel MAPK (Ginty et al., 1994) . We shall address the question of how independently regulated pathways specifically target similar substrates in a later section.
Activation at the Membrane: JAK/STAT Pathways
The JAK/STAT pathways, which are involved in the transcriptional activation of many cytokine-and growth factorinducible genes, illustrate how combinatorial interactions at the receptor itself can determine the kind of transcription complex activated and consequently the nature of the target DNA sequence (for reviews see Darnell et al., 1994; Ihle et al., 1994) . STAT proteins, which prior to receptor activation appear to be cytoplasmic (Schindler et al., 1992) , at least transiently associate with their cognate receptors during activation (Fu and Zhang, 1993; Lutticken et al., 1994) . Phosphorylation at a conserved tyrosine at their C-termini (see Figure 1) allows STAT dimerization; an unknown mechanism then allows them to leave the receptor and migrate to the nucleus.
STAT activation by cytokine receptors lacking intrinsic kinase activity involves specific members of the JAK (Janus kinase) family that are associated with the receptor (for review see Ihle et al., 1994 ; see Table 4 ). For example, activation by interferons a and y (IFN(~ and IFNy) involves JAK1-TYK2-receptor or JAK1-JAK2-receptor complexes, respectively, and in both cases requires the presence of both kinases (Darnell et ai., 1994; Ihle et al., 1994) . Although many receptors activate the same JAKs, they activate different STATs (see Table 4 ). For example, both the IFNa and interleukin-2 (IL-2) receptors activate JAK1, but STAT1 is activated only by the IFN(~ receptor (Beadling et al., 1994) . It is likely that specificity of interactions between receptor phosphotyrosines and the STAT SH2 domain restricts which STATs can be recruited to a particular receptor (Greenlund et al., 1994; Hou et al., 1994) . The mechanism of STAT activation by receptor tyrosine kinases such as the epidermal growth factor (EGF), ptatelet-derived growth factor (PDGF), and colony-stimulating factor 1 (CSF1) receptors is less clear; however, EGF stimulation of A431 cells does induce JAK1 phosphorylation , and STAT1 activation by EGF requires specific EGF receptor phosphotyrosines (Silvennoinen et al., 1993) .
Differential STAT activation leads to variation in transcriptional activation owing to differential DNA target specificity. The STAT proteins can bind DNA in two distinct ways. First, different homo-and heterodimeric STAT combinations have subtly different sequence specificities and bind sites related to the IFNy-activated sequence (GAS) element (Ruff-Jamison et al., 1993; Sadowski et al., 1993; Akira et al., 1994; Darnell et al., 1994; Wakao et al., 1994) . Second, STAT proteins bind the ISRE (IFN-stimulated regulatory element) as a heterotrimeric complex, ISGF3, which contains STAT1 and STAT2 together with p48, a member of the IRF-1 transcription factor family. Only the IFNa receptor, which can activate both STAT1 and STAT2, can activate ISGF3 . As yet, it is unlikely that the full repertory of STAT DNA-binding complexes and DNA targets has been established.
Activation in the Cytoplasm: NF-KB and Dorsal
In mammalian cells activity of NF-KB is regulated by its association with an inhibitory subunit, IKB, which retains the inactive factor in the cytoplasm. NF-KB is activated by many agents that induce acute phase responses, such as IL-1, IL-2, tumor necrosis factor a (TNF~), bacterial lipopolysaccharide (LPS), viral infection, double-stranded RNA, and activation of PKC; the factor is constitutively active in B cells (for review see Baeuerle and Henkel, 1994) . In Drosophila, the recently identified NF-KB-related factor Dif also mediates immunity responses, while its better characterized relative dorsal (dl) mediates dorsoventral patterning (for references see St Johnston and NessleinVolhard, 1992; Ip et al., 1993) . The NF-KB-type proteins provide a case in which regulated factors either activate or repress transcription in response to signals (for references see Kirov et al., 1993; Lehming et al., 1994) . Genetic studies of Drosophila dl activation have provided a framework for our understanding of NF-KB activation. Translocation of dl to the nucleus is regulated by the interaction of the Toll receptor (whose cytoplasmic domain is related to that of the mammalian IL-1 receptor [Gay and Keith, 1991 ] ), with its ligand, Sp&tzle (Morisato and Anderson, 1994) . Like NF-KB, dl is retained in the cytoplasm by an h<B homolog, cactus (for references see . Loss-of-function mutants in cactus result in predominantly nuclear localization of dl along the dorsoventral axis. Regulation of dl by Toll involves phosphorylation, since activity of a kinase, pelle, is required for regulated nuclear translocation (Shelton and Wasserman, 1993) . In contrast, regulation of mammalian NF-KB is less well understood: no mammalian pe//e homologs have as yet been identified. However, in vitro, phosphorylation of h<B by various kinases leads to loss of its ability to inhibit DNA binding by NF-KB (for review see , and in vivo, activation of NF-~cB is correlated with h<B phosphorylation and rapid degradation by the ubiquitin-proteasome pathway Cordle et al., 1993; Henkel et al., 1993; Mellits et al., 1993; Miyamoto et al., 1994; Palombella et al., 1994) .
Given the diverse stimuli that activate NF-KB, it is possible that there exist several pathways rather than a common messenger system and that the convergence point between them may be the phosphorylation of IKB itself. Some recent findings support this view. In HeLa cells, selective ablation of the dou ble-stranded RNA-dependent protein kinase (PKR) inhibits activation of NF-~<B by double-stranded RNA (Maran et al., 1994) ; moreover, in vitro experiments suggest h<B is inactivated following phosphorylation by PKR . However, PKR does not appear to be involved in NF-KB activation by TNF~ (Maran et al., 1994) : this may involve the sphingomyelin pathway and ceramide-activated protein kinases (Kolesnick and Golde, 1994 ). An alternative view is that NF-KB inducers inactivate h<B via a common pathway.
Many stimuli that activate NF-KB stimulate the production of reactive oxygen intermediates, while antioxidants suppress activation of NF-KB by a variety of stimuli; however, the mechanism by which reactive oxygen intermediates activate NF-KB remains obscure (for review see Baeuerle and Henkel, 1994) .
Activation by Dual Signaling Pathways: NF-AT
A further level of complexity in signal-regulated transcriptional activation occurs when activation of a single transcription factor requires signaling via more than one signal pathway, as in the case of NF-AT, the nuclear factor of activated T cells, which regulates the promoters of cytokine genes such as IL-2. Activation of NF-AT, which is a complex of two factors, requires activation of both calciumand PKC-dependent signaling pathways by the T cell receptor (Flanagan et al., 1991;  for review see Rao, 1994) . One N F-AT component is a preexisting cytoplasmic factor, NF-ATp/c, which is retained in the cytoplasm by an unknown mechanism Northrop et al., 1994) . NF-ATp/c is activated by a calcium-dependent pathway involving phosphatase PP2B/calcineurin: however, although one of the candidate NF-ATp/c proteins is a substrate for this enzyme , it remains to be shown that this dephosphorylation regulates factor activity in vivo. The activation of NF-ATp/c appears to require solely its regulated nuclear transfer, since cytoplasmic extracts from unstimulated cells are competent to form the NF-AT complex when added to extracts containing its other component, which is nuclear. Activation of the nuclear NF-AT component, which is composed of AP1 family members, requires activation of PKC and is dependent on new protein synthesis; recent results suggest that full activation of AP1 in T cells may require both calcium-and PKC-dependent pathways (Lee and Gilman, 1994; Su et al., 1994 ).
Attenuation of the Transcriptional Response
The initial transcriptional response of cells to growth factor stimulation is usually transient; however, although our knowledge of the mechanisms by which transcription is induced is extensive, relatively little is known about how it is attenuated. Negatively acting factors may be present prior to stimulus or be synthesized as part of the response to it. Indeed, inhibition of protein synthesis potentiates the strength and duration of many signal-induced transcriptional responses (see Greenberg et al., 1986) , although these data must be interpreted cautiously since some protein synthesis inhibitors themselves activate signaling pathways (Mahadevan and Edwards, 1991 ; Kyriakis et al., 1994) .
Inducible negatively acting factors act either directly to reduce transcription factor activity or indirectly by downregulating the signal pathway itself (Table 5) . Examples of direct-acting inducible proteins include IKB, which sequesters active NF-•B (LeBail et al., 1993; Cheng et al., 1994; Chiao et al., 1994) ; ICER (inducible cAMP early repressor), which competes with CREBs for target sites (Molina et al., 1993) ; and Fos, which may inhibit SRE activity (Alessi et al., 1993; Sun et al., 1993; Doi et al., 1994; Marshall, 1995 [this issue of Ce//]). As yet little is known about the identity or regulation of enzymes that inactivate transcription factors: many of these will be phosphatases, although in the case of yeast heat shock factor, specific induced phosphorylations may mediate down-regulation (Hoj and Jakobsen, 1994) . It is likely that phosphatase PP1 is responsible for the dephosphorylation of CREB Ser-133 (Hagiwara et al., 1992; AIberts et al., 1994b) while phosphatase PP2A may be responsible for dephosphorylation of the TCF Elk-1 (for references see Treisman, 1994) . Although it remains unclear whether the activity of CREB or TCF phosphatases is regulated by extracellular signals, it is interesting to note that a peptide inhibitor of PP1 can be inactivated by protein kinase A phosphorylation in vitro (Beullens et al., 1993) .
Maintenance of Signal Specificity
In this section we consider how signal identity is maintained between related pathways that may share common components and discuss the factors that govern which transcription factors respond to a particular pathway. Specificity of this kind is essentially determined by the specificity of the interactions between successive molecules in a signaling pathway: when the receptor for the signal is itself the transcription factor, as in the nuclear hormone receptors, the problem disappears.
Association of signaling components into relatively stable complexes is likely to play an important role in maintaining signal specificity by physically restricting access of signaling molecules to potential substrates. As discussed above, even though the same JAKs may be activated by different receptors, the spectrum of STATs activated by a particular receptor is apparently governed by specific physical interactions among STATs, JAKs, and receptors. Similarly, in the S. cerevisiae pheromone response MAPK pathway, the STE5 protein apparently acts as a docking platform for other components of the cascade, which may limit cross-talk between it and the other MAPK pathways (Ammerer, 1994; Choi et al., 1994; Marcus et al., 1994) , while FUS3, one of the MAPKs at the end of this pathway, can be coprecipitated with its presumptive targets, including STE12 (Elion et al., 1993) .
A major determinant of signal specificity is the substrate specificity of the kinases involved, about which relatively little is known. For example, substrates for the different proline-directed MAPKs cannot easily be distinguished on the basis of sequences in the immediate vicinity of the phosphorylation sites. Recent studies of J NK/SAPKs suggest that additional physical interactions between the kinase and regions of the substrate distinct from the sites of phosphorylation can also be important for specific substrate recognition. Deletion of the Jun 8 domain, a region N-terminal to the phosphorylation sites, reduces the strength of interaction between Jun and JNK/SAPK in vitro and abolishes N-terminal Jun phosphorylation in vitro and in vivo (Adler et al., 1992; Hibi et al., 1993) . Different JNK/ SAPK isoforms encoded by differentially spliced mRNAs appear to have different affinities for Jun, suggesting that they may have subtly different substrate specificities Sluss et al., 1994) . However, it is not yet clear whether Jun and JNK/SAPKs form stable physical complexes in vivo (Hibi et al., 1993; .
Activation of a transcription factor through phosphorylation at multiple sites by the same kinase might also in principle provide a mechanism by which signal specificity is maintained or even enhanced. Conceptually, this idea is similar to the use of multiple low specificity DNA-binding subunits to generate complexes with increased DNA binding specificity. A requirement for multiple modifications would amplify small differences in the efficiency of phosphorylation by different enzymes, especially if a phosphatase were simultaneously active or kinase activity transient. This would increase specificity at the bottom of a pathway by setting a threshold for factor activation and would also allow tolerance of signal-independent noise or low level "cross-talk" between pathways. The TCF Elk-1 provides a potential example of this since its activation requires phosphorylation at seven different S/T-P motifs by ERK2 (for review see Treisman, 1994) .
Finally, the DNA binding specificities of transcription factors themselves provide an important way by which the targets for a signal pathway can be varied. Many factors bind DNA as dimers or heterodimers with related proteins, which may differ in DNA binding specificity. For example, Jun will bind with Fos to AP1 target sites but with ATF2 or CREB to CRE-like sequences (Benbrook and Jones, 1994) , and different STAT dimers have subtly different sequence specificities (Ruff-Jamison et al., 1993; Sadowski et al., 1993) . Factor interactions may also enhance binding specificity. For example the TCFs, whose DNAbinding domains have an inherently broad binding speci-ficity, are targeted to a subset of Ets motifs th rough cooperative DNA binding with SRF (for review see Treisman, 1994) . A more extreme example of this is the recruitment of transcription factors to target promoters by protein-protein rather than protein-DNA interactions, which may mediate recruitment of STE12 to a-specific promoters in S. cerevisiae (Yuan et al., 1993) .
Specificity of the Transcriptional Response
Our discussion so far has been limited to pathways and mechanisms that govern the activation of particular transcription factors in response to a given stimulus. What determines which genes are activated by these factors, and why is it that many stimuli induce the same signal pathways yet activate different genes? Several relatively well-characterized examples suggest how combinatorial interactions of signaling pathways and transcription factors introduce specificity into the transcriptional response to extracellular signals.
Cell-Type Specific Transcriptional Regulation
The differential response of different cell types to signals depends crucially on a cell's developmental history, which manifests itself in two ways. First, target elements for regulated transcription factors may either be in an accessible chromatin conformation or inaccessible in condensed chromatin. Second, combinatorial interactions of regulated factors with cell-type specific transcription factors will allow differential regulation in different cell types.
The pheromone response in S. cerevisiae provides an example in which such interactions are understood in detail. The differential response of a or a cells to pheromone does not reflect differences in the signaling pathways activated by the two cell type-specific pheromone receptors, because substitution of one receptor/pheromone combination by the other has no effect on the spectrum of genes activated in a given cell (Bender and Sprague, 1986; see Herskowitz, 1995) . In both a and c( cells, pheromone activates the STE12 transcription factor via the MAPK pathway, but some of the targets for STE12 are cell-type specific, owing to the activity of the cell type-specific MAT proteins (see Herskowitz, 1995) . In a cells, the MATal protein binds a-specific promoters, which allows STE12 recruitment; in contrast, a-specific promoters bind MAT(~2, which prevents the access of STE12 to sequences within these promoters by a system of chromatin-mediated repression involving the global transcriptional regulators SSN6 and TUP1 (see Cooper et al., 1994) . In a cells, STE12 cannot be recruited to its (z-specific targets owing to the absence of MATer1, but its a-specific targets are now accessible owing to the lack of MATa2.
Combinatorial Interactions Can Increase Specificity of the Transcriptional Response
The activity of many promoters apparently requires the simultaneous presence of multiple transcription factors. Although the mechanistic basis of this requirement remains to be established, it is clearly a major determinant of specificity in the response to extracellular signals. For example, if a single promoter contains multiple signalregulated elements required for its activation, stimuli that can simultaneously activate all of these elements will activate transcription, while stimuli that efficiently activate only a subset of them will not. Similarly, if such interactions occur between factors regulated by different receptors, integration of signals from more than one receptor can occur. Combinatorial interactions between transcription factors bound at a promoter may also qualitatively change transcription factor behavior, in extreme cases affecting whether a signal-regulated transcription factor activates or represses transcription. In addition, if such interacting factors are themselves synthesized in response to the initial stimulus, activity of a target promoter can be prolonged or curtailed.
Activation of the IFNI~ promoter provides a good example of how the requirement for multiple signal inputs at a promoter can generate specificity. This promoter, which is activated following viral infection, contains several positively and negatively acting elements, including an NF-KB site, that apparently direct formation of a highly organized protein-DNA complex (for review see Thanes et al., 1993) . The intact IFNI3 promoter is insensitive to many agents that can activate NF-KB, such as LPS and phorbol esters, even though these agents can efficiently activate model promoters containing multiple copies of the NF-KB site, presumably because they cannot simultaneously activate the other IFNI3 regulatory elements. A similar mechanism may underlie the differential response of the c-fos gene to IFN(~ and PDGF: although both agents efficiently induce binding of STAT factors to the c-fos promoter, it is likely that only PDGF can efficiently activate other cooperating c-fos promoter elements that are required for efficient transcription, such as the SRE (Hannigan and Williams, 1992) .
Combinatorial interactions may allow genes to be induced with different kinetics in response to the same stimulus. An example is the differential kinetics of transcriptional activation of the IL-2 and TNF(~ genes in response to T cell receptor stimulation. Induction of IL-2 gene transcription is dependent on activation of both PKC-and calcium-dependent signaling pathways and requires new protein synthesis. Both stimuli are required for activation of the NF-AT complex and for full activation of AP1, which is necessary for activation of other sites within the promoter; stimuli that activate the PKC-dependent pathway alone have no effect (for references see Lee and Gilman, 1994; Rao, 1994; Suet al., 1994) . In contrast, activation of the TNFa promoter is more rapid, requiring only the calcium-dependent pathway and the NF-AT component NF-ATp/c and occuring independently of new protein synthesis (McCaffrey et al., 1994) . In this case the differential timing of activation of the two genes in response to the same stimulus is determined by the different factorbinding sites at the two promoters. Similarly, during growth factor stimulation of fibroblasts, synthesis of the egr-1 transcription factor prolongs the transcription of the subset of other growth factor-induced genes that contain egr-1 sites in their promoters, such as nur77 (Williams and Lau, 1993) .
A good example of how simple combinatorial interactions can both modify transcription factor activity and inte-grate signal inputs from different signaling pathways is provided by the interaction of the Toll and torso pathways at Drosophila ventral repression elements (VREs) (Rusch and Levine, 1994) . Although the Drosophila NF-KB homolog dl activates transcription in other promoter contexts, at VREs it acts with "corepressor" factors to inhibit transcriptional activation by other promoter elements. VRE activity requires dl and is therefore dependent on the Toll signaling pathway; it is also negatively regulated by the torso receptor, acting via the MAPK pathway, which may interfere with dl-corepressor interactions (Rusch and Levine, 1994) . VRE-controlled genes such as zerknDllt (zen) and decepentaplegic (dpp) are therefore repressed in ventral and lateral regions of the Drosophila syncytium where dl is activated by Toll, but remain active at the poles, where the Toll and torso pathways are simultaneously active (see Figure 2 , line 5; Kirov et al., 1993; Lehming et al., 1994) ,
Differential Effects of Signal Strength or Duration: Thresholds
Recent studies have demonstrated that PC12 cells can either differentiate or proliferate in response to growth factor stimulation according to the strength or duration (or both) of the stimulus (Traverse et al., 1994; Dikic et al., 1994; Marshall, 1995) . At present the mechanism of this is unknown, but it is instructive to consider how small quantitative differences in signal strength can be turned into large qualitative differences in gene expression. Such phenomena might appear puzzling to signal transductionists, but come as no surprise to developmental biologists. The generation of dorsoventral polarity in the Drosophila embryo syncytium provides an example (St Johnston and NLisslein-Volhard, 1992) . In this case, differential activation of the Toll receptor over the dorsoventral axis causes the nuclear concentration of the dl morphogen to become graded, being greatest in the ventral region and poles of the embryo (St Johnston and N0sslein-Volhard, 1992; Rusch and Levine, 1994) . At dl target promoters, the number and relative affinity of dl-binding sites, together with cooperative interactions between dl and other transcription factors (which may act at the level of DNA binding or transcriptional activation), effectively sets a particular threshold dl concentration for transcriptional activation (Figure 2 ; . This limits the expression of key zygotic regulatory genes and thereby defines specific domains of the embryo. For example, promoters that contain only low affinity dl-binding sites are expressed only where dl levels are highest, while those containing high affinity dl sites together with other cooperating sites are expressed even where dl levels are lowest (Figure 2 , lines 1-3). Further specificity is provided by the combinatorial interaction of dl with a repressor, snail (sna), itself the product of a dl target gene. Promoters containing both dl and sna sites, such as that of rhomboid (rho), are specifically activated only in those regions of embryo in which the dl concentration is insufficient to induce sna expression (Figure 2, line 4) . Finally, as mentioned above, atthe poles the activity of dl as a repressor is regulated by a combinatorial interaction between the Toll and torso signaling pathways (Figure 2 , line 5).
Perspective
The dl system provides the best example of how small differences in signal input can generate large differences (2) Activation of promoters such as those of twist (twl) or sna that contain either high affinity dl sites or low affinity dl sites with collaborating E boxes, respectively, requires a lower concentration of nuclear dl and therefore occurs throughout a more expanded region. (3) Activation of promoters that contain both high affinity sites and collaborating E boxes requires only a low level of nuclear dl and occurs throughout the ventral region. (4) Some promoters in this latter class such as those of rho also contain sna-binding sites and are therefore repressed in the region, shown by a broken line, in which dl levels are high enough to activate the sna repressor gene: activation therefore only occurs in regions where sna is absent. (5) DI acts to repress transcription via VREs that are composed of high affinity dl-binding sites with sites for corepressors. Activity of genes containing VREs, such as dpp and zen, is repressed throughout the region where dl is nuclear; outside this region, the genes are activated by other promoter elements. At the poles, the torso pathway inactivates the VREs, and hence zen and dpp are expressed despite the high nucJear dl levels. Figure adapted from . in transcriptional response. It is well understood because differentially regulated target genes are available, and the system is amenable to genetic analysis; moreover, it also emphasizes the importance of interactions between regulated transcription factors and the products of genes under their control. In contrast, although many growth factorregulated genes have been identified in mammalian cells, our understanding of the function of these genes is rudimentary. Many growth factor-induced genes themselves encode transcription factors, and it is presumablythe interaction between these factors and preexisting factors, including those activated by the stimulus itself, that ultimately determines the response of the cell to the stimulus. Given the potential complexity of such interactions, it is conceivable that even if two different stimuli induce the same set of genes, small differences in relative expression might result in qualitatively different patterns of subsequent transcription. This will be the most interesting area of future research for those interested in growth factorregulated transcription.
